Amgen Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other
pharmaceutical manufacturers in North America:
sales of $20.41 billion
of which 34%
Eli Lilly and Company
of which 35%
was Endocrinology), and
of which 100%
was Pharmaceutical Products).
Amgen Inc. reported sales of $21.66 billion
December of 2015.
increase of 8.0%
versus 2014, when the company's sales were $20.06 billion.
Sales at Amgen Inc. have increased during each of the previous five years
(and since 2010, sales have increased a total of 44%).